Category: Legislative

Legislative

Legislative

House Bill on Sharing Certain Information about Investigational Products Moves Forward

House Bill on Sharing Certain Information about Investigational Products Moves Forward

Jan. 22, 2018 – The House Energy and Commerce Subcommittee on Health held a markup Jan. 17 that advances H.R. 2026 (http://bit.ly/2G4cRM1), the “Pharmaceutical Information Exchange Act,” which will clarify how drug and medical device companies can share health care economic or scientific information about investigational drugs or devices with payers and formulary committees. “By […]

Read more

Legislative

Sen. McCaskill Files Tax Bill Amendment to Eliminate Ad Tax Deduction

Sen. McCaskill Files Tax Bill Amendment to Eliminate Ad Tax Deduction

Nov. 13, 2017 – While it seemed like the elimination of the pharma advertising tax deduction was not on the tax bill table, Sen. Claire McCaskill (D-Mo.) today filed an amendment to eliminate that tax deduction. “Although we’re taking this seriously, a Senate Democrat filing an amendment to a Republican-controlled bill is perhaps not a […]

Read more

Legislative

Elimination of Ad Tax Deduction Is Not in Tax Bill

Elimination of Ad Tax Deduction Is Not in Tax Bill

Nov. 2, 2017 – In a memo sent to Coalition for Healthcare Communication members today, CHC Executive Director John Kamp reported that the Republican tax bill just announced “DOES NOT contain a provision to reduce the immediate deductibility of marketing costs, meaning we survived the first hurdle in this tax bill. Kamp told Coalition members […]

Read more

Legislative

Kamp: N.J. Proposed Rule Would Hurt, Not Help Opioid Situation

Kamp: N.J. Proposed Rule Would Hurt, Not Help Opioid Situation

Oct. 19, 2017 – A New Jersey proposal to both prohibit prescribers from accepting even moderate meals and cap compensation for speeches, consulting or other services from pharmaceutical companies – in an attempt to target the unnecessary prescription of opioids – actually could be counterproductive in meeting that goal, according to Coalition for Healthcare Communication […]

Read more

Legislative

Congress Should Make Lowering Drug Prices a Top Priority, POLITICO-Harvard Poll Says

Congress Should Make Lowering Drug Prices a Top Priority, POLITICO-Harvard Poll Says

Oct. 2, 2017 – According to a recent poll conducted by POLITICO and Harvard T.H. Chan School of Public Health, 40 percent of those surveyed said that lowering prescription drug prices should be Congress’ number one priority for the remainder of 2017. Just 26 percent of the public stated that repealing and replacing Obamacare should […]

Read more

Legislative

NJ Governor Christie Calls for $10k per Year Cap, Restrictions on Pharma Gifts to Physicians

NJ Governor Christie Calls for $10k per Year Cap, Restrictions on Pharma Gifts to Physicians

Sept. 6, 2017 – In a first-of-its-kind move, New Jersey Gov. Chris Christie has issued a regulation capping physician incomes by limiting gifts from pharmaceutical companies to $10,000 per year and prohibiting gifts of entertainment and lavish meals, according to an article published today in Policy and Medicine. The article notes that although several other […]

Read more

Legislative

Congress Passes FDA User Fee Legislation

Congress Passes FDA User Fee Legislation

Aug. 7, 2017 – In a 94-1 vote, the U.S. Senate on Aug. 3 passed FDA user fee reauthorization legislation that will revise and extend the user fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products through 2022. H.R. 2430, the FDA Reauthorization Act of 2017, was passed by the House […]

Read more

Legislative

State Legislators Move to Increase Transparency, Limit Gifts and Payments to Physicians

State Legislators Move to Increase Transparency, Limit Gifts and Payments to Physicians

July 5, 2017 – While deregulation takes hold in the Trump administration in Washington, the states are predictably working to fill the void. For medical transparency and “sunshine,” California, Maine and Nevada are currently very active. All three states have taken legislative action in recent months to restrict the ability of pharmaceutical companies to furnish […]

Read more

Legislative

States Make Moves to Ease, Restrict Medical Communications

States Make Moves to Ease, Restrict Medical Communications

March 31, 2017 – With Congress in a seemingly permanent state of gridlock, individual states are taking actions that may affect how companies can communicate about their products within state borders. Arizona will soon become the first state to allow industry to communicate truthful off-label information about its products; Vermont has introduced a resolution calling […]

Read more

Legislative

Holcombe’s E&C Testimony: PDUFA VI Will Take Patient-focused Drug Development to New Level

Holcombe’s E&C Testimony: PDUFA VI Will Take Patient-focused Drug Development to New Level

March 23, 2017 – In testimony before the House Energy and Commerce Committee’s Subcommittee on Health yesterday, Biotechnology Industry Organization Senior Vice President of Science Policy Kay Holcombe praised the success of industry user fees paid to the FDA to improve the drug review process and called on the subcommittee to reauthorize the Prescription Drug […]

Read more